Search

MMJ accepts rival offer for subsidiaries

MMJ Phytotech has accepted a competing bid for the spin-out of its medical cannabis-focused Canadian subsidiaries onto the TSX Venture Exchange, with the new deal worth $C42 million ($A41 million).

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/01/18

1 year TSR5 year TSR
23rdDigitalX713%-1%
88th4DS Memory160%10%
114thPainChek131%-24%
149thMMJ Phytotech89%0%
709 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

12/12/17
$450 Issued
12/12/17
$0 Issued
12/12/17
$150 Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

190th↓DigitalX$87k
191st↓MMJ Phytotech$76k
193rd↑PainChek$74k
194th↓4DS Memory$58k
234 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from MMJ Phytotech

423rdAndreas Gedeon$316k
624thJason Bednar$219k
974thWinton Willesee$106k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer